Connection

Sriharsha Tella to Prognosis

This is a "connection" page, showing publications Sriharsha Tella has written about Prognosis.
Connection Strength

0.464
  1. Second-line therapies in advanced biliary tract cancers. Lancet Oncol. 2020 01; 21(1):e29-e41.
    View in: PubMed
    Score: 0.116
  2. Survival and prognostic factors in patients with pancreatic squamous cell carcinoma. Eur J Surg Oncol. 2019 Sep; 45(9):1700-1705.
    View in: PubMed
    Score: 0.111
  3. Predictors of Survival in Adrenocortical Carcinoma: An Analysis From the National Cancer Database. J Clin Endocrinol Metab. 2018 09 01; 103(9):3566-3573.
    View in: PubMed
    Score: 0.106
  4. Association Between Treatment Facility Volume, Therapy Types, and Overall Survival in Patients With Stage IIIA Non-Small Cell Lung Cancer. J Natl Compr Canc Netw. 2019 03 01; 17(3):229-236.
    View in: PubMed
    Score: 0.027
  5. Predictors of survival, treatment patterns, and outcomes in histiocytic sarcoma. Leuk Lymphoma. 2019 02; 60(2):553-555.
    View in: PubMed
    Score: 0.026
  6. T cell/histiocyte-rich large B cell lymphoma: incidence, demographic disparities, and long-term outcomes. Br J Haematol. 2019 04; 185(1):140-142.
    View in: PubMed
    Score: 0.026
  7. Natural Killer/T-cell Neoplasms: Analysis of Incidence, Patient Characteristics, and Survival Outcomes in the United States. Clin Lymphoma Myeloma Leuk. 2018 07; 18(7):475-479.
    View in: PubMed
    Score: 0.026
  8. A prognostic scoring model for survival after locoregional therapy in de novo stage IV breast cancer. Breast Cancer Res Treat. 2018 Aug; 170(3):677-685.
    View in: PubMed
    Score: 0.026
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.